Skip to content
HTuO Biosciences logo — HTuO Biosciences is a drug discovery company that works at t...

HTuO Biosciences

HTuO Biosciences is a drug discovery company that works at the interface of physics, chemistry, & computer programming.

Founded 2020 Canada Canada 22 employees Total: $3.25M Biotechnology, Pharmaceutical

General Information

Company Name HTuO Biosciences
Founded Year 2020
Location Canada Canada
Employees 22
Industries Biotechnology, Pharmaceutical
Business Model B2B, Platform, SaaS
Revenue Model Subscription, Licensing, Project Based
Social

BounceWatch is an independent company data service, not affiliated with HTuO Biosciences. To contact HTuO Biosciences, visit htuobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HTuO Biosciences compare?

A PDF of HTuO Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HTuO Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 26, 2026

HTuO Biosciences will be presenting at Life Science BC’s Invest in BC on November 3-4, 2026.

Growth Metrics Oct 22, 2026

HTuO's HT2 platform processes over 20,000 drug-target interactions per day, operating 10x faster than equivalent AI.

About HTuO Biosciences

HTuO Biosciences, founded in 2020, is a cutting-edge player in the Biotechnology and Pharmaceutical industries, headquartered in Canada. With its slogan, "HTuO Biosciences is a drug discovery company that works at the interface of physics, chemistry, & computer programming," the company emphasizes its unique interdisciplinary approach to drug discovery.

The core of HTuO Biosciences lies in its proprietary advanced molecular simulation technology. By integrating principles of chemistry, physics, and computer programming, the startup is positioned to revolutionize the way we predict molecular behavior with increased accuracy—a critical factor for the progress of drug discovery processes.

In terms of financial traction, the company secured a Seed Round investment on 01 January 2022 with participation from the Archangel Network of Funds and York Angels Investors. This strategic investment reflects confidence in their innovative solution and growth potential.

Business keywords: drug discovery, molecular simulation, deep tech, computational chemistry, molecular physics, computer programming, predictive modeling, interdisciplinary science, molecular dynamics, advanced simulation technologies, physics-based modeling, chemistry informatics

Services & Products

Advanced simulation for drug discovery
Development of transformative therapeutics
Collaboration with pharmaceutical and life sciences industries

Target Customers

Pharmaceutical companies Biotech firms Life sciences organizations Scientific research community

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Angel $750.00K -
01 Jan 2026
Angel $1.00M -
01 Jul 2024
Angel $1.50M 6
Archangel Network of Funds, E-Fund +4
01 Apr 2022

HTuO Biosciences Alternatives & Competitors

View All Alternatives
HTuO Biosciences vs
Verseon
Verseon United States

Game-Changing Technology, Life-Changing Medicines

22 employees
Biotechnology, Health and Wellness
HTuO Biosciences vs

Mine enhanced chemical space. Design superior candidates

28 employees
Biotechnology, Information Technology
HTuO Biosciences vs
AQEMIA
AQEMIA France

Scale drug discovery with quantum-inspired physics and generative AI

87 employees
AI, Biotechnology

FAQ About HTuO Biosciences

HTuO Biosciences is a drug discovery company that works at the interface of physics, chemistry, & computer programming.
HTuO Biosciences was founded in 2020.
HTuO Biosciences is headquartered in Canada.
HTuO Biosciences operates in Biotechnology and Pharmaceutical. Its work centres on drug discovery, molecular simulation, deep tech and computational chemistry. Its customers include Pharmaceutical companies, Biotech firms and Life sciences organizations.
HTuO Biosciences has a B2B, Platform and SaaS business model. Its revenue comes from Subscription, Licensing and Project Based.
HTuO Biosciences has approximately 22 employees.
HTuO Biosciences has completed 3 funding rounds, raising a total of $3.25M.
HTuO Biosciences offers: Advanced simulation for drug discovery, Development of transformative therapeutics, Collaboration with pharmaceutical and life sciences industries.
Top alternatives and competitors to HTuO Biosciences include Verseon, Pharmacelera, AQEMIA, Numerate, PharmCADD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HTuO Biosciences and Verseon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HTuO Biosciences, https://bouncewatch.com/company/htuo-biosciences, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout